HPV相关口咽癌淋巴结比率预后阈值识别
该回顾性队列研究纳入169例接受经口机器人手术的HPV相关口咽鳞状细胞癌患者,评估淋巴结比率(LNR)对生存和复发的预后价值。多因素Cox回归显示LNR每增加1%对应调整HR 1.04(CI 1.02-1.07),最小P法得出LNR≥17%为阈值,其无病生存HR 4.34(95%CI 1.24-15.2)。
要点
- 连续LNR每增加1%与复发风险独立相关(调整HR 1.04)。
- LNR≥17%阈值可识别复发高风险患者(无病生存HR 4.34)。
- 在淋巴结检出数≥18枚时LNR预后价值更显著(HR 5.05)。
核心结论
- 对于HPV相关OPSCC,连续LNR和17%阈值有助于在淋巴结数量之外识别复发病例。
研究设计与样本
- 回顾性队列研究,纳入169例连续接受经口机器人手术治疗的HPV相关OPSCC患者。
主要发现
- 多因素Cox回归显示LNR每增加1%对应调整HR 1.04(CI 1.02-1.07)。
- 在淋巴结检出数≥18枚时调整后LNR的HR为5.05(95%CI 1.38-18.47)。
- 最小P法得出LNR≥17%阈值,其无病生存HR为4.34(95%CI 1.24-15.2)。
关键数值与推荐
- LNR阈值定为≥17%。
- 淋巴结检出数≥18枚时LNR预后价值更显著。
临床怎么用
- 临床可考虑计算LNR,并以17%为阈值辅助识别HPV相关OPSCC术后复发高风险患者。
局限性
- 证据等级为4级,为回顾性单系统研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the utility of lymph node ratio (LNR) as a prognostic factor for survival and recurrence in surgically treated patients with human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC). STUDY DESIGN: Retrospective cohort study. METHODS: In this retrospective cohort study of a tertiary healthcare system in a major metropolitan area, we reviewed 169 consecutive patients with HPV-related OPSCC treated using transoral robotic surgery. Univariable and multivariable Cox proportional hazards regression analysis with stratified models were used to compare LNR with other traditional clinicopathologic risk factors forrecurrence and survival. An LNR cutoff was found using the minimal P approach. RESULTS: Multivariable Cox regression models showed that each additional percentage increase in LNR corresponded to an adjusted hazard ratio (HR) of 1.04 (confidence interval [CI] 1.02-1.07). LNR was more significant when adjusted for adequate lymph node yield of ≥ 18 nodes (HR 5.05, 95% confidence interval [CI] 1.38-18.47). The minimal P generated cutoff point at LNR ≥ 17% demonstrated a HR 4.34 (95% CI 1.24-15.2) for disease-free survival. CONCLUSION: For HPV-related OPSCC, continuous LNR and an LNR threshold of 17% could be helpful in identifying recurrent disease in addition to measures such as lymph node number alone. LEVEL OF EVIDENCE: 4.
引用
- Bu DD, Ferrandino R, Robinson EM, et al. Lymph Node Ratio in HPV-Associated Oropharyngeal Cancer: Identification of a Prognostic Threshold. Laryngoscope. 2020. PMID: 32348558. doi:10.1002/lary.28689
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。